Biotech and Pharmaceuticals Life Sciences

More

  • DAVOS/ LONDON, Jan 20- The Gavi global alliance for vaccines and immunisation group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus. Gavi said the agreement would help the U.S. drugmaker take the experimental Ebola vaccine through late-stage...

  • We are prepared for the future: DSM CEO Wednesday, 20 Jan 2016 | 1:20 AM ET
    We are prepared for the future: DSM CEO

    Feike Sijbesma, CEO of DSM, says the industry is changing the world transitions from fossil fuels to bio-renewable energy and discusses the economy in Europe and China.

  • Funds who placed a broad array of bets produced some of the strongest gains, beating star managers like Bill Ackman, David Einhorn and Larry Robbins who invested more narrowly and ended 2015 with steep losses. Funds to produce double-digit returns in 2015 include Citadel, Millennium Management, Visium Asset Management, Tourbillon Capital Partners and...

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the vaccine, HEPLISAV-B, was rejected in February 2013 by the U.S. Food and Drug Administration, which sought additional...

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, sending its shares up 9.4 percent in premarket trading. An earlier application was rejected by the FDA in February 2013. Dynavax's shares closed at $21.18 on the Nasdaq on Wednesday.

  • Jan 7- Dutch biotech UniQure NV said on Thursday its experimental gene therapy for a blood disorder benefited some patients in an early-stage study, sending its shares up about 20 percent in light premarket trading. UniQure said after being treated with the drug, four out of five patients were able to fully discontinue taking prophylactic rFIX, which is...

  • UniQure reports promising data from gene therapy trial Thursday, 7 Jan 2016 | 6:33 AM ET

    Jan 7- Dutch biotech UniQure NV said its experimental gene therapy for a blood clotting disorder benefited some patients in an early-stage study.

  • Dec 20- Martin Shkreli, the pharmaceutical executive facing U.S. charges of securities fraud, lost control of his Twitter account to hackers on Sunday, hours after he took to Twitter to plead his innocence, his spokesman said. "It was hacked," Craig Stevens, a spokesman for the former chief executive of Turing Pharmaceuticals, said in an email. "We have been working with...

  • Dec 18- Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli has been under investigation for securities fraud related to hedge fund MSMB Capital Management and...

  • Dec 18- Privately held drugmaker Turing Pharmaceuticals Inc is close to replacing Chief Executive Martin Shkreli, the Wall Street Journal reported on Friday, a day after the FBI arrested him on charges of securities fraud. Shkreli was charged in a federal indictment on Thursday related to his time managing hedge fund MSMB Capital Management and CEO of...

  • Turing Pharma close to replacing CEO Shkreli - WSJ Friday, 18 Dec 2015 | 11:21 AM ET

    Dec 18- Privately held drugmaker Turing Pharmaceuticals Inc is close to replacing Chief Executive Martin Shkreli, the Wall street Journal reported on Friday, a day after the FBI arrested him on charges of securities fraud. Shkreli was charged in a federal indictment on Thursday related to his time managing hedge fund MSMB Capital Management and CEO of...

  • NEW YORK, Dec 17- Martin Shkreli, the boyish pharmaceutical entrepreneur who caused a public uproar after he drastically raised the price of a life-saving prescription drug, was arrested on Thursday for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund and a pharmaceutical company he previously headed.

  • NEW YORK, Dec 17- Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed. The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and...

  • NEW YORK, Dec 17- Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed. The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and...

  • Dec 16- The U.S. Food and Drug Administration on Wednesday approved Eli Lilly& Co's diabetes drug Basaglar, a cheaper version of Sanofi AG's top-selling drug Lantus. In September Lilly entered a settlement agreement to resolve patent litigation with Sanofi over Basaglar, allowing Lilly and its partner, Boehringer Ingelheim, to launch Basaglar in the United...

  • Dec 16- Array BioPharma Inc said its experimental drug helped patients with a form of skin cancer live longer without their cancer progressing, in an ongoing late-stage study. Array is the first, and likely the only company developing an agent specifically to target this difficult-to-treat population- at least for the foreseeable future, Chief Executive Ron...

  • Dec 16- Array BioPharma Inc said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in an ongoing late-stage study. The company's stock jumped about 24 percent before the opening bell on Wednesday. The stock closed at $3.83 on the Nasdaq on Tuesday.

  • Dec 16- Drug developer Array BioPharma Inc said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in a late-stage study.

  • Attention China: You can buy cans of clean Canadian air

    Harrison Wang, China spokesperson of Vitality Air, explains the concept behind the Canada-based company which sells cans of clean air.

  • PARIS, Dec 9- Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end. Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but...